You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

List of Excipients in API octreotide


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing octreotide

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Chiesi USA Inc MYCAPSSA octreotide 10122-550 AMMONIA
Chiesi USA Inc MYCAPSSA octreotide 10122-550 FERROSOFERRIC OXIDE
Chiesi USA Inc MYCAPSSA octreotide 10122-550 GELATIN
Chiesi USA Inc MYCAPSSA octreotide 10122-550 GLYCERYL MONOCAPRYLATE
Chiesi USA Inc MYCAPSSA octreotide 10122-550 MAGNESIUM CHLORIDE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Start Trial

Excipients in ANDA-approved (generic) drugs containing octreotide

Company Ingredient NDC Excipient
Hikma Pharmaceuticals USA Inc. octreotide acetate 0641-6174 LACTIC ACID, L-
Hikma Pharmaceuticals USA Inc. octreotide acetate 0641-6174 SODIUM CHLORIDE
Hikma Pharmaceuticals USA Inc. octreotide acetate 0641-6174 SODIUM HYDROXIDE
Hikma Pharmaceuticals USA Inc. octreotide acetate 0641-6174 WATER
Teva Parenteral Medicines Inc octreotide acetate 0703-3301 ACETIC ACID
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Start Trial

Detailed excipient profiles for octreotide

Excipient focus: ACETIC ACID

Excipient focus: AMMONIA

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: GELATIN

Excipient focus: GLYCERYL MONOCAPRYLATE

Excipient focus: LACTIC ACID

Excipient focus: LACTIC ACID, L-

Excipient focus: MAGNESIUM CHLORIDE

Excipient focus: MANNITOL

Excipient focus: METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER

octreotide drug variants not containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER

Company Ingredient NDC
Novartis Pharmaceuticals Corporation octreotide acetate 0078-0180
Hikma Pharmaceuticals USA Inc. octreotide acetate 0641-6174
Teva Parenteral Medicines Inc octreotide acetate 0703-3301
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc octreotide acetate 23155-685
Sagent Pharmaceuticals octreotide acetate 25021-451
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: PHENOL

Excipient focus: POLYSORBATE 80

Excipient focus: POVIDONE K12

Excipient focus: PROPYLENE GLYCOL

Excipient focus: SHELLAC

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM ACETATE

Excipient focus: SODIUM BICARBONATE

Excipient focus: SODIUM CAPRYLATE

Excipient focus: SODIUM CHLORIDE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRICAPRILIN

Excipient focus: TRIETHYL CITRATE

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links